Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 50 Women only

Giving a single oral antibiotic dose with Bulkamid urethral bulking.

Official title: Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid

Run by Ohio State University · NCT06706362 · Data updated 2026-11-12

This will see if one dose of oral antibiotics given before Bulkamid urethral bulking lowers early urinary tract infections in people treated for stress‑predominant urinary incontinence.

More Stress Urinary Incontinence trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment138 (estimated)
SponsorOhio State University
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedApril 15, 2027
Study endsOctober 15, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT06706362 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people evaluated at The Ohio State University who plan to undergo Bulkamid urethral bulking for stress or stress‑predominant mixed urinary incontinence, have a negative preoperative UTI test, and a post‑void residual ≤150 mL.

Probably not a fit

Patients with recurrent UTIs, contraindications or allergies to the study antibiotics, those undergoing additional pelvic procedures, or those already on daily antibiotics are unlikely to be eligible or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for Bulkamid urethral bulking are randomized and blinded to receive either a single preoperative oral antibiotic (trimethoprim/sulfamethoxazole or nitrofurantoin based on allergy) or a placebo. The primary outcome is the rate of postoperative urinary tract infection in the immediate postoperative period. Secondary analyses will compare UTI rates and treatment success between patients discharged with an indwelling catheter versus those using intermittent self‑catheterization and will examine whether number of injection sites correlates with outcomes. Patients complete validated symptom and satisfaction questionnaires before the procedure, at 6 weeks, and at 1 year to track symptom improvement and patient satisfaction.

Why it matters

Potential benefit: If successful, giving a single prophylactic oral antibiotic at the time of Bulkamid could reduce early postoperative urinary tract infections and improve recovery.

How similar studies have gone: Perioperative antibiotics have reduced UTI risk in some urologic procedures, but prophylaxis specifically for Bulkamid urethral bulking has limited prior data and is not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Patients evaluated by a pelvic floor specialist (either urogynecologist or urologist) at The Ohio State University with plans to undergo urethral bulking with Bulkamid for stress urinary incontinence or mixed urinary incontinence (stress predominant).
* Negative testing for UTI in pre-operative work-up (including either negative urine culture or urine dip negative for infection).
* Office evaluation with evidence of SUI either with urodynamic studies (UDS) or positive cough stress test (CST).
* Post-void residual volume of 150 mL or less (measured by either catheterization or bladder scan)

Exclusion Criteria

* Contraindications to both oral antibiotics including antibiotic allergies or significant renal disease
* Patient undergoing additional pelvic organ prolapse procedures or other urologic procedures concomitantly
* Recurrent UTIs, defined as 3 or more UTIs within the past 12 months or 2 UTIs within the past 6 months
* Patients currently taking daily antibiotic prophylaxis for any reason
* Non-English speaking patients
* Pregnant patients
* Pelvic organ prolapse stage greater than 2
* Patients with immunosuppression due to underlying medical conditions
* Recent antibiotic treatment within one week of the procedure

Where it's running

  • The Ohio State University Wexner Medical Center OB/GYN Female Pelvic Medicine and Reconstructive Surgery
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.